Salvianolic acid B can ameliorate atherosclerosis in LDLR-/- mice and alleviate LPS-induced inflammation in RAW264.7 cells by inhibiting the phosphorylation of STAT3/NF-κB. Here, NFKB1 is linked to atherosclerosis.